Okoduwa Stanley I R, Umar Isamila A, James Dorcas B, Inuwa Hajiya M
Department of Biochemistry, Ahmadu Bello University, Zaria 811104, Nigeria.
Directorate of Research and Development, Nigerian Institute of Leather and science Technology, Zaria 810221, Nigeria.
Medicines (Basel). 2017 Oct 11;4(4):73. doi: 10.3390/medicines4040073.
: (OG) is used in the traditional management of diabetes in Nigeria. This study investigated the anti-diabetic potential of OG leaf fractions (OGLF) in a rat model of Type-2 diabetes (T2D). : Methanol crude extract of OG leaf was fractionated with solvents of increasing order of polarity (-hexane, chloroform, ethyl-acetate, -butanol and water). The anti-diabetic potential of the fractions was evaluated in vivo. T2D was induced in Albino Wistar rats and treated with OGLF. : The T2D rats showed significant elevation in serum levels of fasting blood glucose (FBG), liver and kidney function biomarkers. At 4-weeks of intervention with OGLF, the untreated diabetic control group maintained severe hyperglycaemia in the presence of 61.7% serum insulin, 17.3% pancreatic β-cell function (HOMA-β) and 51.5% Insulin sensitivity. The glucose tolerance ability was enhanced in the -butanol-fraction (OGb) treated group. With 74.8% available serum insulin and 38.6% improvement in insulin sensitivity, the OGb treated group had a 63.5% reduction in FBG and it was found to be most effective as it ameliorates a majority of the changes caused in the studied parameters in diabetic rats. : The data from this study suggest that OGb fraction is a potential candidate for the development of an effective drug for the management of T2D.
在尼日利亚,秋葵(OG)被用于糖尿病的传统管理。本研究在2型糖尿病(T2D)大鼠模型中研究了秋葵叶提取物(OGLF)的抗糖尿病潜力。:用极性递增的溶剂(正己烷、氯仿、乙酸乙酯、正丁醇和水)对秋葵叶的甲醇粗提物进行分离。对各提取物的抗糖尿病潜力进行体内评估。在白化Wistar大鼠中诱导T2D,并给予OGLF治疗。:T2D大鼠的空腹血糖(FBG)、肝功能和肾功能生物标志物血清水平显著升高。在用OGLF干预4周时,未治疗的糖尿病对照组在血清胰岛素水平为61.7%、胰腺β细胞功能(HOMA-β)为17.3%和胰岛素敏感性为51.5%的情况下维持严重高血糖。正丁醇提取物(OGb)治疗组的葡萄糖耐量能力增强。OGb治疗组的血清胰岛素水平为74.8%,胰岛素敏感性提高38.6%,空腹血糖降低63.5%,并且发现其最为有效,因为它改善了糖尿病大鼠研究参数中引起的大多数变化。:本研究数据表明,OGb提取物是开发用于管理T2D的有效药物的潜在候选物。